Patients For Affordable Drugs NOW

P4ADNOW’s Executive Director, @GlobalDiaBEATes, breaks down how Big Pharma games the patent system to keep prices and profits high, and how we are working to stop patent abuse to ensure more competition in the drug market and lower drug costs. Be part of this fight because together we can win. youtube.com/watch?v=BupFd3…

Use your voice to help change policy! Share your story with P4ADNOW: actionnetwork.org/forms/base-sto… ¡Usa tu voz para cambiar las políticas! Comparte tu historia con P4ADNOW: actionnetwork.org/forms/base-sto…

The ETHIC Act would reduce drug company patient abuse by addressing duplicative patenting but Big Pharma's lobbyists are hard at work against it. Help us fight Big Pharma greed. Send a letter to your representative urging them to put patients first by supporting the ETHIC Act today: tinyurl.com/3bynbf37

Polling from @KFF reveals about 43% of adults in the US have skipped, rationed, or gone without a prescription drug due to cost in the past year. At Patients For Affordable Drugs, we believe that no one should have to make the impossible choice between the medications they need to live and other bills. Visit P4ADNOW.org to learn more and join the fight for lower prescriptions drug prices.

When Big Pharma games the patent system, patients pay the price but there are bipartisan bills in Congress that are smart, practical steps to lower prescription drug prices. By strengthening coordination between the U.S. Patent and Trademark Office (USPTO) and the U.S. Food and Drug Administration (FDA), we could ensure fewer opportunities for patent manipulation, more transparency in how patents are granted and enforced, and faster access to affordable medications for patients. Americans shouldn’t have to pay more because of bureaucratic silos. Let's ensure the system works for people, not just pharmaceutical companies.

Patents could keep an Ozempic generic off the U.S. market until at least 2031, reintroduced legislation would forbid large health care companies that own PBMs from directly owning pharmacies, and tariffs are reshaping how companies operate, but not addressing the root causes of high drug prices. Read more at our Week in Review: tinyurl.com/2t9xa45r

Kris Garcia, un Defensor de Pacientes de P4AD, paga $10,000 al mes por sus medicamentos. Debibo a esto, Kris ha tenido que tomar decisiones muy dificiles para asegurarse de que pueda seguir sano. Si tu o alguien que conoces tiene una historia personal con el alto costo de los medicamentos recetados, comparte tu historia con P4AD: actionnetwork.org/forms/base-sto…

Brand-name drug companies are manipulating the patent system to keep generics off the market. This ensures drug prices stay high while patients struggle to afford them. Learn more about patent thickets and other Big Pharma schemes at PatientsPushForCompetition.org

P4AD patient advocate Jackie relies on the 2022 prescription drug law's $2,000 cap on out of pocket costs to afford the medication she needs to survive. To learn more about the 2022 prescription drug law and how it's helping patients save money at the pharmacy, visit MedicareNegotiation.org

According to a recent @KFF poll, 30% of Hispanic adults and 24% of Black adults in the US say they are very worried about being able to afford prescription medications for themselves or their families. For many families from these marginalized communities, concerns about the cost of medication go far beyond a single pharmacy trip and can lead to rationing and delaying medications or choosing not to fill a prescription at all. While recent reforms have helped lower out-of-pocket costs for patients on Medicare in particular, there are still too many families who are struggling to afford the medications they need. There are bipartisan bills in Congress that would lower drug prices for patients, learn more at: PatientsForAffordableDrugsNOW.org

As debate continues around new proposals to lower prescription drug prices for Americans, one thing is clear: the 2022 prescription drug law is already helping to lower costs for millions of patients across the country. As of January 1, 2026, all major provisions of the law are in effect. What began as a series of phased-in reforms has lowered out-of-pocket costs, improved access, and brought greater predictability to millions of Americans. As policymakers look ahead at a time when nine in ten Americans are calling on Congress to do more to lower prescription drug costs, these real-world impacts underscore the importance of building on what’s working and addressing the remaining barriers that keep patients from accessing and affording the medications they need.

Over 40,000 vetted patient stories are now featured on P4AD’s interactive map, new report finds that pharmaceutical companies are increasingly using patent thickets to delay generic competition, and pharmaceutical companies participating in TrumpRx increased their federal lobbying spending by nearly 23%. Read more at our Week in Review: tinyurl.com/2tcbves6 Get the latest updates on drug pricing reforms and patient advocacy efforts from Patients For Affordable Drugs NOW delivered straight to your inbox! Subscribe here: tinyurl.com/mubcwjd

Si quieres tener la oportunidad de viajar a Washington D.C. para compartir tu historia con los altos precios de los medicamentos recetados, únete a la comunidad de P4AD. Es importante que tus legisladores escuchen tu historia. Comparte tu historia hoy: actionnetwork.org/forms/base-sto…

According to a new poll by @KFF, 42% of Make America Healthy Again (MAHA)-supporting voters identified lowering the cost of health care as more important than other issues tied to the movement. And 61% registered voters said the cost of health care will have a “major impact” on which party’s candidate they support in the midterm elections. Read more here: tinyurl.com/3456wn2j

The ETHIC Act would reduce drug company patient abuse by addressing double patenting but Big Pharma's lobbyists are hard at work against it. Help us fight Big Pharma greed. Send a letter to your representative urging them to put patients first by supporting the ETHIC Act today: tinyurl.com/3bynbf37

Congress is hearing from Big Pharma lobbyists right now. The question is whether they’ll also hear from you... For the past two weeks, patient advocates from across the country flew to D.C. to sit across from lawmakers and deliver a clear message: pass the ETHIC Act. One of them was Maureen, who traveled from Florida. She’d never done anything like this before. She walked into those meetings not knowing what to expect — just knowing she had to try. "These people work for us," she said after. "If we don't try, we might as well throw in the towel." Now we need to back her up. The ETHIC Act targets one of Big Pharma’s most effective delay tactics: filing dozens of duplicative patents on existing drugs to block cheaper generics from reaching patients. It’s legal and deliberate, and it's why so many drugs that should be affordable aren’t. ETHIC would make those patents easier to challenge — and get lower cost alternatives to patients faster. Maureen showed up. Our advocates showed up. Your letter is how you show up. Contact your representative about supporting the ETHIC Act today: tinyurl.com/3bynbf37

Las farmacéuticas de marca están manipulando el sistema de patentes para mantener altos los precios de los medicamentos, y los pacientes están enfrentando dificultades. Aprende más sobre el _product hopping_ y otras prácticas de la gran industria farmacéutica en Es.PatientsPushForCompetition.org en el enlace de nuestra biografía.

When Big Pharma games the patent system, patients pay the price. But there are bipartisan bills in Congress that are smart, practical steps to take on Big Pharma's patent abuse strategies and would bring lower cost competition to market faster. Visit PatientsPushForCompetition.org to learn more and get involved.

SCOTUS examines skinny labels, Pfizer struck agreements to delay competition for its blockbuster Vyndamax until 2031, and new polling shows 64% of adults worried about the cost of health care. Read more at our Week in Review: tinyurl.com/4kva4h47 Get the latest updates on drug pricing reforms and patient advocacy efforts from Patients For Affordable Drugs NOW delivered straight to your inbox! Subscribe here: tinyurl.com/mubcwjd

Keeping up to date on the biggest news in drug pricing has never been easier with P4ADNOW's Week In Review! Published every Friday, our Week In Review rounds up the latest news and important conversations in drug pricing and delivers them straight to your inbox. Stay informed, subscribe now: mailchi.mp/654be71cbbf5/w…